Randox Laboratories Ltd.

Revolutionary Randox Technology Offers Multiple Cardiac Tests within Minutes

A new revolutionary Biochip Analyser that will save cardiac patients lives by providing immediate diagnosis at the point of care has been launched by Randox.

Cardiovascular disease is a progressive and complicated condition, covering a spectrum of biochemical processes which are different in many patients. Multiple markers are required to provide an accurate diagnosis but it is essential this is available rapidly in the A&E department.

The Randox Evidence MultiStat is a revolutionary new desktop analyser which offers cardiac results within just 20 minutes. This innovative new technology ensures the accuracy and precision of a commercial laboratory analyser within the A & E department delivering significant benefits for patients by rapidly identifying risk and enabling accurate clinical decisions.

With some blood biomarkers only detectable for 6 hours after a heart attack, patients presenting with early symptoms are often missed. The Evidence MultiStat will ultimately save patient lives by giving accurate and timely diagnosis when time is at a premium. The Evidence MultiStat is based upon the award winning Biochip technology from Randox for simultaneous detection of multiple analytes.

The Evidence MultiStat also offers an array for drugs of abuse with arrays for stroke, metabolic syndrome, cancer, fertility disorders, thyroid disorders and synthetic steroids in development. The system is suitable for a variety of point of patient environments including emergency departments, cardiac units, doctor surgeries, forensic units, rehab units and employee drug screening centres. The technology offers fully automated pipetting, incubation, washing, imaging and report generation ensuring that the MultiStat can be used by non technical staff. User friendly touch screen Windows ® based software also ensures little or no training is required.

About Randox
Randox is an international diagnostics company, headquartered in the UK. Randox develop, manufacture and market clinical diagnostic products worldwide. Core products are: Biochip Array Technology; clinical chemistry analysers and reagents; quality controls and EQA; recombinant proteins and antibodies.

For further information contact:

Randox Laboratories
Diamond Road
Co. Antrim BT29 4QY
United Kingdom

Tel: +44 (0) 28 9442 2413
Fax: +44 (0) 28 9445 2912